MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Home・Akciju saraksts・Microbot Medical Inc

Search

Microbot Medical Inc

Slēgts

2.28 -2.56

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.26

Max

2.34

Galvenie mērījumi
By Trading Economics
Ienākumi	113K -3.5M
Darbinieki	43
EBITDA	-561K -4.1M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+220.51% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 12. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-11M 158M
Iepriekšējā atvēršanas cena	4.84
Iepriekšējā slēgšanas cena	2.28

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 20. apr. 23:49 UTC

Galvenie ziņu notikumi

New Zealand 1Q Inflation Higher Than Expected

2026. g. 20. apr. 23:10 UTC

Karstas akcijas

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

2026. g. 20. apr. 22:53 UTC

Galvenie tirgus virzītāji

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

2026. g. 20. apr. 23:45 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

2026. g. 20. apr. 23:44 UTC

Tirgus saruna

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

2026. g. 20. apr. 23:39 UTC

Tirgus saruna

Rio Tinto Posts Strong Start to Year -- Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 20. apr. 23:30 UTC

Tirgus saruna

Super Retail's Earnings Outlook Less Rosy -- Market Talk

2026. g. 20. apr. 23:09 UTC

Tirgus saruna

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

2026. g. 20. apr. 22:31 UTC

Iegādes, apvienošanās, pārņemšana

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026. g. 20. apr. 22:26 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Aims for Acquisition to Be Completed by End-2026

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

2026. g. 20. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Acquisition Would Be for A$175 Million

2026. g. 20. apr. 22:24 UTC

Iegādes, apvienošanās, pārņemšana

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

2026. g. 20. apr. 22:15 UTC

Iegādes, apvienošanās, pārņemšana

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026. g. 20. apr. 22:01 UTC

Iegādes, apvienošanās, pārņemšana

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

2026. g. 20. apr. 21:38 UTC

Tirgus saruna

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

2026. g. 20. apr. 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

2026. g. 20. apr. 21:24 UTC

Tirgus saruna

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

2026. g. 20. apr. 21:24 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 20. apr. 21:13 UTC

Peļņas

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

2026. g. 20. apr. 21:10 UTC

Peļņas

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

2026. g. 20. apr. 21:09 UTC

Peļņas

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

2026. g. 20. apr. 21:08 UTC

Peļņas

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

2026. g. 20. apr. 21:07 UTC

Peļņas

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

2026. g. 20. apr. 21:05 UTC

Peļņas

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

2026. g. 20. apr. 21:05 UTC

Peļņas

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

220.51% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 220.51%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

3

Pirkt

0

Turēt

0

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Citi krājumi no sektora

MDT

Medtronic PLC

85.26

A

Agilent Technologies Inc

120.85

VEEV

Veeva Systems Inc

168.97

HQY

HealthEquity Inc

86.11

NEOG

Neogen Corp

9.63

Live chat